Trial Profile
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia: a 12-week, randomised, double-blind, parallel-group, placebo controlled, international multicentre study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2021
Price :
$35
*
At a glance
- Drugs Aladorian (Primary)
- Indications Ventricular arrhythmias
- Focus Therapeutic Use
- Sponsors IRIS
- 20 Dec 2021 This trial has been completed in Hungary, according to European Clinical Trials Database record.
- 16 Dec 2021 This trial has been completed in France, according to European Clinical Trials Database record.
- 28 Feb 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.